Image of Jennifer J. Furin

Jennifer J. Furin, M.D., Ph.D.

Jennifer Furin, MD, PhD, is an infectious diseases clinician and a medical anthropologist who focuses on global health. She received her PhD in Medical Anthropology from the University of California at Los Angeles in 1995 and her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women’s Hospital in 2002 and her fellowship in infectious diseases at University Hospitals Case Medical Center (Cleveland) in 2004. Dr. Furin is engaged in clinical and program work and operational research to support the treatment of multidrug-resistant tuberculosis and HIV. She has been fighting drug-resistant TB since 1995 when she began working in Lima, Peru with Partners In Health. She has significant global experience and has done work in Haiti, Peru, Russia, Lesotho, South Africa, Georgia, Bangladesh, Swaziland, and Tajikistan. She is also a member of the Tuberculosis Transformation Science Committee of the AIDS Clinical Trials Group. She serves as a high-level consultant for a number of National TB Programs, WHO, USAID, and Médecins Sans Frontières

Affiliations:

Dr. Furin is also an adjunct assistant professor in the Department of Anthropology at Case Western Reserve University

Dr. Furin is the director of Clinical Capacity Building for the Sentinel Project on Pediatric Drug-Resistant Tuberculosis

Dr. Furin is participating in teaching and research in the Department's Sentinel Project on Pediatric Drug-Resistant Tuberculosis.

Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.
Authors: Authors: Guglielmetti L, Hewison C, Avaliani Z, Hughes J, Kiria N, Lomtadze N, Ndjeka N, Setkina S, Shabangu A, Sikhondze W, Skrahina A, Veziris N, Furin J.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
Authors: Authors: Furin J, Diacon AH, Andries K.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis.
Authors: Authors: Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Peloquin CA, Alsultan A, Thiel BA, Debanne SM, Boom WH, Diacon AH, Johnson JL.
Antimicrob Agents Chemother
View full abstract on Pubmed
An update on repurposed medications for the treatment of drug-resistant tuberculosis.
Authors: Authors: Mafukidze A, Harausz E, Furin J.
Expert Rev Clin Pharmacol
View full abstract on Pubmed
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges.
Authors: Authors: Tadolini M, Garcia-Prats AJ, D'Ambrosio L, Hewison C, Centis R, Schaaf HS, Marais BJ, Ferreira H, Caminero JA, Jonckheere S, Sinha A, Herboczek K, Khaidarkhanova Z, Hayrapetyan A, Khachatryan N, Urtkmelidze Ia, Loreti C, Esposito S, Matteelli A, Furin J, Varaine F, Migliori GB.
Eur Respir J
View full abstract on Pubmed
The experience of bedaquiline implementation at a decentralised clinic in South Africa.
Authors: Authors: Cariem R, Cox V, de Azevedo V, Hughes J, Mohr E, Durán LT, Ndjeka N, Furin J.
Public Health Action
View full abstract on Pubmed
Update in Tuberculosis/Pulmonary Infections 2015.
Authors: Authors: Koenig SP, Furin J.
Am J Respir Crit Care Med
View full abstract on Pubmed
Access to new drugs and the global drug-resistant TB crisis: a case series from KwaZulu-Natal, South Africa.
Authors: Authors: Master I, Furin J.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Drug-Resistant Tuberculosis: Challenges and Progress.
Authors: Authors: Kurz SG, Furin JJ, Bark CM.
Infect Dis Clin North Am
View full abstract on Pubmed
Outbreak of multidrug-resistant tuberculosis on Daru Island.
Authors: Authors: Furin J, Cox H.
Lancet Respir Med
View full abstract on Pubmed